World Marrow Donor Association standards are aimed at enhancing the quality of unrelated volunteer donor hematopoietic stem cell registries assisting transplant physicians in the international search for unrelated donors for their patients. The standards cover: (1) general organization of registries; (2) donor recruitment; (3) donor characterization; (4) information technology; (5) facilitation of search requests; (6) second/subsequent donations; (7) collection/processing/transport of stem cells; (8) follow-up of patient/donor; and (9) financial/ legal responsibilities.
tion
Today, approximately one-third of unrelated transplantations worldwide utilize hematopoietic stem cells from a donor in another country. 1 An international voluntary organization of registries worldwide, the World Marrow Donor Association (WMDA), 2 has published policies and procedures for these international exchanges (http:// www.worldmarrow.org). [3] [4] [5] The WMDA recently adopted standards and is beginning an accreditation process; both of these are aimed at enhancing the quality of the international search and procurement process. Accreditation of individual registries by the WMDA will be an indication that these registries are committed to follow WMDA standards. These standards promote the quality of procedures necessary to obtain, in the shortest possible time, the appropriate quality and quantity of hematopoietic stem cells from the best unrelated donor suitable for engrafting a patient while protecting the anonymity, health, and well being of the volunteer donor. The standards are based on recommendations published previously 6 and were developed with the input of international experts in transplantation, histocompatibility, and registry operations. I.
OVERVIEW AND DEFINITIONS 1.0 These standards are intended to provide the minimum criteria for obtaining WMDA accreditation. 1.01. In the initial implementation of the accreditation process by WMDA, specific 'benchmark' standards have been identified that must be met by a registry seeking accreditation. These standards have been indicated in bold. Other standards, not in bold, are not required during the initial implementation process. Registries certified during the initial implementation period will be granted a 'pilot' accreditation status based on their commitment to adhere to the 'benchmark' standards. The WMDA Board will establish the length of the initial implementation period. Following the initial implementation phase, requirements to meet specific standards will follow standard 1.02. 1.02 After the initial implementation period is completed, the words 'must' and 'shall' indicate that deviations are not acceptable. There will be no difference between bolded benchmark standards and nonbolded standards containing the words 'must' and 'shall'. 'Should', 'might', and 'may' are used for recommendations that are not mandatory. 1.03 If national laws and regulations differ from the WMDA standards, the requirement to meet local legal standards will be accepted as a valid cause for variation from WMDA standards.
Definitions
WMDA: An international nonprofit organization that promotes the definition and standardization of ethical, technical, medical, and financial aspects of hematopoietic stem cell transplantation involving volunteer donors in one country who give hematopoietic stem cells to unrelated patients in another country.
WMDA Board: The board includes the President, VicePresidents, Secretaries, Treasurer, Chief Operating Officer, and Chairs of the WMDA Working Groups.
Note: The institutions providing hematopoietic stem cells to a patient in another country vary in their organizational structures. The definitions below are aimed at defining the individual elements, which comprise this effort and are not intended to indicate the requirement for a specific organizational structure.
Registry: A Registry is a national organization whose responsibility is to process requests for hematopoietic stem cells from donors originating from within the country and emanating from abroad. The Registry may coordinate the activities of Donor, Collection, and Transplant Centers in the respective country.
Donors: Donors are defined as (1) volunteer adult donors of hematopoietic stem cells or (2) umbilical cord blood units collected after maternal permission.
Donor Center: The Donor Center is the organization responsible for recruiting, consenting, counseling, and coordinating the testing of prospective donors. The Center monitors the short-and long-term health of adult volunteer donors who have provided hematopoietic stem cells. The Donor Center maintains a register or database of donors, which may be searched as appropriate.
Cord Blood Bank: A Donor Center whose sole mission is to collect and maintain umbilical cord blood units is termed a Cord Blood Bank and may combine some or all of the activities of both a Donor Center and a Collection Center. For example, a Cord Blood Bank may be responsible for donor recruitment, cord blood collection, and storage, but the database of donors might be maintained by a Registry. Alternatively, the Cord Blood Bank might include all of these activities and perform searches for Transplant Centers.
Collection Center: The Collection Center is the medical facility at which hematopoietic stem cell collection from selected donors actually takes place. This collection might include marrow aspiration or apheresis. The Collection Center performs the medical workup of the donor and provides the final approval of the donor for harvest. If umbilical cord blood is collected, the Center is responsible for processing and storage of the cord blood unit.
Transplant Center: The Transplant Center is the medical facility at which a patient (recipient) receives a transplant (graft) with hematopoietic stem cells from an unrelated donor or from an umbilical cord blood unit. The Center oversees the immediate medical treatment and provides long-term follow-up of the recipient. The Search Unit undertakes the search for an unrelated donor for specific patients. This entity may be contained within a Transplant Center or may be separate from the Transplant Center. If separate, the Search Unit may coordinate searches for one or several Transplant Centers. In the standards, reference to a Transplant Center should be interpreted as a Transplant Center and/or a Search Unit as appropriate. Transplant Centers/Search Units seeking an international donor work through the Registry in their country.
Testing Laboratories: These laboratories perform the histocompatibility, blood group, infectious disease, and other testing of the prospective donors and patients. They may be under the direction of a Registry, Donor Center or Transplant Center or may be separate from these entities.
Blood Bank: A Blood Bank is a medical facility at which blood intended for transfusion is drawn and stored.
Confirmatory Typing: This typing includes the tests carried out on a specific donor at the request of a Transplant Center to determine the appropriateness of using hematopoietic stem cells from that donor for a specific patient.
WorkUp nance, and operations must be validated. Documentation of systems development, maintenance, and operations including policies and procedures must be complete and in an appropriate language. Modifications to the computer system must be authorized and documented. 5.05 Search algorithms must allow reliable searches, which can be completed in a time frame consistent with WMDA recommendations. 5.06 Each printed report must be dated. Quality assurance procedures should include dating each step in the search process in order to evaluate the time required for each stage of the search process.
6.0
Facilitation of search requests 6.01 Critical communications between Registries or between a Registry and a Transplant Center must be in writing. 6.01.1 These communications should contain a signature of authorization and be sent by fax or email. 6.02 Registries must respond to search requests and to requests for additional information and/or an aliquot of donor sample within a time period consistent with WMDA recommendations and in a defined manner. 6.02.1 The policy of the Registry regarding repetition of the database search for a specific patient should be defined. 6.03 Donor and patient identity must remain confidential during the search process so that only appropriate Registry personnel have access to these data. 6.04 A donor selected for a specific patient must be placed on a 'reserved' status from the time of confirmatory typing until the transplantation date is reached. 6.04.1 A maximum time limit and the procedures for granting exceptions for this status should be set in writing. 6.05 Adult volunteer donors must be counseled when selected for further tests and when selected as a donor for a specific patient. Follow-up of patient and donor 9.01 The Registry must have policies and procedures for the short-term follow-up and care of adult volunteer donors for conditions related to the hematopoietic stem cell donation. Short term is defined as within the first year following donation. 9.02 The Registry must have policies for the longterm follow-up and care of adult volunteer donors for conditions related to the hematopoietic stem cell donation. Long term is defined as the time period following the first year after donation and extending for at least four years. 9.03 Donor health issues potentially affecting the health of a patient receiving a hematopoietic stem cell donation from that donor must be reported to the Transplant Center. 9.04 Adverse events affecting donors undergoing harvest of hematopoietic stem cells and occurring long term as a consequence of the donation must be defined and must be recorded. 9.04.1 Reports of adverse events should be submitted to the Registry involved tional donations in 2002. The WMDA standards and registry accreditation process will enhance the quality of the management of international searches and donations for those patients in need of unrelated donors.
